To identify functionally essential downstream targets of METTL16 in HCC, we conducted transcriptome-wide RNA sequencing (RNA-seq), protein mass spectrometry (MS), RNA immunoprecipitation-sequencing (RIP-seq), and ribosome profiling. The gene discussed is METTL16; the disease is hepatocellular carcinoma.